Stay updated on Apatinib Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.5.3 to v3.5.4, indicating an update to the site; no study content or critical data was altered.
    Difference
    0.1%
    Check dated 2026-05-14T23:09:25.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, replacing Revision: v3.5.2. This reflects a minor site/version update rather than any changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-30T17:41:54.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:44:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page content.
    Difference
    0.1%
    Check dated 2026-03-18T17:46:22.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T15:13:42.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Updated the site revision to v3.4.2 and removed the government funding status notice that accompanied v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:04:45.000Z thumbnail image

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.